Molly Henderson, CFO and CBO of Phathom Pharmaceuticals ($PHAT), made one open market sale of company shares in the last year, totaling $16,740, with the most recent on April 7, 2025. This ranks 11,120th among 11,678 insiders by sale value, well below the average of $8.6 million across about 6.4 transactions. She had no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 3678 | $4.55 | 91,779.2700 | 63,176,210 | 3.85% | 0.01% |
| Feb. 27, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Common Stock | 72000 | $0.00 | 167,457.2700 | 63,176,210 | 75.43% | 0.11% |
| Feb. 27, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 63,176,210 | 9999.99% | 0.08% |
| Jan. 21, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 6583 | $6.59 | 95,457.2700 | 63,176,210 | 6.45% | 0.01% |
| Dec. 19, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 1291 | $8.00 | 100,067.2700 | 64,627,847 | 1.27% | 0.00% |
| July 15, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 4325 | $11.72 | 101,358.2700 | 51,289,092 | 4.09% | 0.01% |
| May 31, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Common Stoock | 7500 | $0.00 | 102,763.0000 | 51,289,092 | 7.87% | 0.01% |
| April 8, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stoock | 3435 | $11.10 | 95,263.0000 | 51,289,092 | 3.48% | 0.01% |
| Jan. 19, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 6307 | $7.75 | 100,609.2700 | 51,289,092 | 5.90% | 0.01% |
| Jan. 18, 2024 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 51,289,092 | 9999.99% | 0.23% |
| Nov. 20, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 2127 | $7.24 | 104,195.2700 | 0 | 2.00% | 0.00% |
| Nov. 1, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Common Stock | 22500 | $0.00 | 118,814.2700 | 0 | 23.36% | 0.00% |
| Nov. 1, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 811 | $7.80 | 118,003.2700 | 0 | 0.68% | 0.00% |
| Nov. 1, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 11681 | $8.95 | 106,322.2700 | 0 | 9.90% | 0.00% |
| July 14, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Common Stock | 25000 | $0.00 | 95,180.0000 | 0 | 35.62% | 0.00% |
| July 14, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Common Stock | 25000 | $1.00 | 96,314.2700 | 0 | 35.06% | 0.00% |
| June 2, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 1960 | $11.41 | 68,844.8600 | 0 | 2.77% | 0.00% |
| May 22, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 2110 | $12.87 | 70,804.8600 | 0 | 2.89% | 0.00% |
| April 6, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 3439 | $7.27 | 72,914.8600 | 0 | 4.50% | 0.00% |
| March 1, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | S | Common Stock | 2032 | $8.53 | 76,353.8600 | 0 | 2.59% | 0.00% |
| Jan. 19, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Common Stock | 33000 | $0.00 | 78,385.8600 | 0 | 72.71% | 0.00% |
| Jan. 19, 2023 | Phathom Pharmaceuticals, Inc. | $PHAT | Henderson Molly | CFO and CBO | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |